Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

Virology Journal

Volumn 9, Issue 1, 2012, Pages

  Treviño, Ana ^a   Aguilera, Antonio ^b   Caballero, Estrella ^c   Benito, Rafael ^d   Parra, Patricia ^a   Eiros, Jose M ^e   Hernandez, Araceli ^f   Calderón, Enrique ^g   Rodríguez, Manuel ^h   Torres, Alvaro ⁱ   García, Juan ^j   Ramos, Jose Manuel ^k   Roc, Lourdes ^l   Marcaida, Goitzane ^m   Rodríguez, Carmen ⁿ   Trigo, Matilde ^o   Gomez, Cesar ^p   De Lejarazu, Raul Ortíz ^e   De Mendoza, Carmen ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL DE CONXO   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^f HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^j Hospital Cristal Pinor   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^l HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

ⁿ CENTRO SANITARIO SANDOVAL   (Spain)

^o Departamento de Neurología   (Spain)

^p HOSPITAL VIRGEN DE LA SALUD   (Spain)

more..

Author keywords

Epidemiology; HTLV; HTLV 3; HTLV 4; Seroprevalence; Spain

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE CARRIER; ENZYME IMMUNOASSAY; FEMALE; HTLV-1 INFECTION; HTLV-2 INFECTION; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SEROPREVALENCE; SPAIN; TREND STUDY; WESTERN BLOTTING; BLOOD; EPIDEMIOLOGY; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; PREVALENCE;

ADULT; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

EID: 84858729772     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-71     Document Type: Article

References (25)

1. Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419.
2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Thé G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
3. Toro C, Blanco F, García-Gascó P, Sheldon J, Benito JM, Rallón NI, Soriano V: HTLV type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with HTLV type 2 following initiation of antiretroviral therapy. Clin Infect Dis 2007, 45:e118-e120.
4. Roucoux D, Murphy E: The epidemiology and disease outcomes of human T lymphotropic virus type II. AIDS Rev 2004, 6:144-154.
5. Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A: Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2005, 2:30.
6. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM: Emergence of unique primate Tlymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA 2005, 102:7994-7999.
7. Calattini S, Betsem E, Bassot S, Chevalier S, Mahieux R, Froment A, Gessain A: New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J Infect Dis 2009, 199:561-564.
8. Bagossi P, Bander P, Bozóki B, Tozser J: Discovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4. Expert Rev Anti Infect Ther 2009, 7:1235-1249.
9. Proietti F, Carneiro-Proietti A, Catalan-Soares B, Murphy E: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
10. Verdonck K, Gonzalez E, Van Dooren S, Vandamme A, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
11. Treviño A, Aguilera A, Caballero E, Toro C, Eiros JM, Ortiz-de-Lejarazu R, Rodríguez-Calviño JJ, Tuset C, Gómez-Hernando C, Rodríguez-Iglesias M, Ramos JM, Rodríguez-Díaz JC, Benito R, Trigo M, García-Campello M, Calderón E, Garcia J, Rodríguez C, Soriano V: Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain. AIDS Res Hum Retroviruses 2009, 25:551-554.
12. Toro C, Jiménez V, Rodríguez C, Del Romero J, Rodés B, Holguín A, Alvarez P, García-Campello M, Gómez-Hernando C, Guelar A, Sheldon J, de Mendoza C, Simón A, Soriano V: Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain. J Med Virol 2006, 78:1599-1608.
13. Treviño A, Soriano V, Grupo Español para el Estudio del VIH-2 y HTLV: Current situation of HIV type 2 and HTLV in Spain. Enferm Infecc Microbiol Clin 2010, 28:442-445.
14. Toro C, Aguilera A, Caballero E, Tuset C, Alvarez P, García-Campello M, Rodríguez-Iglesias M, de Lejarazu RO, Eiros J, Rodriguez C, del Romero J, Benito R, Calderón E, Santana O, Amor A, Gómez-Hernando C, García J, Soriano V: Hospital-based surveillance for HTLV-1/2 infections in Spain. AIDS Res Hum Retroviruses 2007, 23:1075-1077.
15. Treviño A, García J, de Mendoza C, Benito R, Aguilera A, Ortíz-de-Lejarazu R, Ramos JM, Trigo M, Eirós JM, Rodríguez-Iglesias M, Torres A, Calderón E, Hernandez A, Gomez C, Marcaida G, Soriano V, HTLV Spanish Study Group: Prevalence of HTLV-1/2 infections in Spain: a cross-sectional hospitalbased survey. AIDS Res Hum Retroviruses 2010, 26:861-864.
16. Instituto Nacional de Estadística: Revisión del padron municipal 2009. 2010, Available in: http://www.ine.es [1/8/2010].
17. Toro C, Rodés B, Bassani S, Jiménez V, Tuset C, Brugal MT, de la Fuente L, Soriano V, HTLV Spanish Study Group: Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain. J Clin Virol 2005, 33:65-70.
18. The HTLV European Research Network: Seroepidemiology of the human Tcell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 14:68-77.
19. Pérez-Cachafeiro S, del Amo J, Iribarren JA, Salavert-Lleti M, Gutiérrez F, Moreno A, Labarga P, Pineda JA, Vidal F, Berenguer J, Moreno S, Cohorts of the Spanish AIDS Research Network (CoRIS and CoRIS-MD): Decrease in serial prevalence of coinfection with hepatitis C virus among HIVinfected patients in Spain, 1997-2006. Clin Infect Dis 2009, 48:1467-1470.
20. Perzova R, Benz P, Abbott L, Welch C, Thomas A, El-Ghoul R, Sanghi S, Nara P, Glaser J, Siegal FP, Dosik H, Poiesz BJ: Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infection. AIDS Res Hum Retroviruses 2010, 26:1229-1231.
21. Mahieux R, Gessain A: The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol (Paris) 2009, 57:161-166.
22. Switzer WM, Hewlett I, Aaron L, Wolfe ND, Burke DS, Heneine W: Serologic testing for human T-lymphotropic virus-3 and -4. Transfusion 2006, 46:1647-1648.
23. Andersson S, Gessain A, Taylor G: Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus (HTLV) types I and II. Virus Res 2001, 78:101-106.
24. Toro C, Rodés B, Poveda E, Soriano V: Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003, 75:102-104.
25. Duong YT, Jia H, Lust JA, Garcia AD, Tiffany AJ, Heneine W, Switzer WM: Short communication: absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia. AIDS Res Hum Retroviruses 2008, 24:1503-1505.